AJP - Regu AJP: Renal Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 286: R431-R444, 2004; doi:10.1152/ajpregu.00361.2003
0363-6119/04 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (94)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tarpey, M. M.
Right arrow Articles by Grisham, M. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tarpey, M. M.
Right arrow Articles by Grisham, M. B.

INVITED REVIEW

Methods for detection of reactive metabolites of oxygen and nitrogen: in vitro and in vivo considerations

Margaret M. Tarpey,1,2 David A. Wink,3 and Matthew B. Grisham4

1Department of Anesthesiology and the 2Center for Free Radical Biology, University of Alabama at Birmingham, Birmingham, Alabama 35294; 3Radiation Biology Branch, National Cancer Institute, Bethesda, Maryland 20814; and 4Department of Molecular and Cellular Physiology, Louisiana State University Health Sciences Center, Shreveport, Louisiana 71130


    ABSTRACT
 TOP
 ABSTRACT
 METHODS TO DETECT OXIDATIVE...
 SUPEROXIDE DETECTION
 DETECTION OF HYDROGEN PEROXIDE
 METHODS TO DETECT NO...
 DETECTION OF S-NITROSOTHIOLS BY...
 QUANTIFICATION OF 3...
 GRANTS
 REFERENCES
 
Facile detection of reactive oxygen and nitrogen species in biologic systems is often problematic. This is a result of the numerous cellular mechanisms, both enzymatic and nonenzymatic involved in their catabolism/decomposition, the complex and overlapping nature of their reactivities, as well as the often limited intracellular access of detector systems. This review describes approaches to the direct and indirect measurement of different reactive metabolites of oxygen and nitrogen. Particular attention to a method's applicability for in vivo determinations will be addressed.

free radical; nitric oxide; superoxide; hydrogen peroxide; peroxynitrite


THE DISCOVERY by McCord and Fridovich (83, 84) that the erythrocyte-associated enzyme superoxide dismutase (SOD) decomposes the free radical superoxide launched a frenzy of research activity that remains unabated over the past 35 years. Indeed, the discovery of SOD defined an entirely new area of biomedical research that represents one of the fundamental advances in biology over the past 50 years. This discovery suggested that reactive free radicals derived from oxygen could be produced in vivo in significant quantities. Until this landmark observation, chemists and biochemists believed that free radicals of any type were much too reactive and therefore much too toxic to be produced in vivo. With investigators more receptive to the idea that small molecular weight reactive radical species play important roles in normal physiology as well as pathophysiology, it was not surprising when Ignarro, Furchgott, and Murad identified the nitrogen-based free radical nitric oxide (NO) as the elusive endothelium-derived relaxing factor (EDRF). In fact, NO has been shown to be important in the homeostatic regulation of the immune, cardiovascular, and nervous systems (55). Reactive oxygen and nitrogen species are now known to play roles in mediating cytotoxicity through alterations in protein, lipid, and nucleic acid structure and function with resultant disruption of cellular homeostatic mechanisms. These overtly noxious consequences are often due to markedly elevated (orders of magnitude) steady-state concentrations or rates of production of reactive species. In addition, however, it has become apparent that more subtle changes in rates of production of reactive species may critically impact cellular homeostasis and may serve physiological roles in initiating signaling cascades. Thus sensitive, specific, and reliable methods to detect changes in reactive species are essential to understanding the roles these substances play in both normal and diseased states.

However, measurement of the in situ production of reactive species is difficult for several reasons. For example, in many tissues, low intracellular steady-state concentrations of superoxide occur as a result of the balance between the basal rates of partial reduction of oxygen to superoxide and the diffusion-limited scavenging of superoxide by both cytoplasmic and mitochondrial SODs, resulting in intracellular superoxide concentrations estimated to rarely exceed 1 nM. (13) Extracellular release of small proportions of intracellularly formed superoxide may occur via diffusion through anion channels (78, 107). In addition, superoxide formed from plasma membrane-bound oxidases remains at relatively low levels due to serum and extracellular fluid components, including low molecular weight oxidant scavengers and the heparin-binding extracellular-SOD (1, 46, 81, 105, 119). Thus the relatively short half-life (seconds) of reactive species and the efficient and redundant systems that have evolved to scavenge them require that any detection technique must be sensitive enough to effectively compete with these intra- and extracellular antioxidant components for reaction with the substance in question. Additionally, methods for analysis of reactive species must have adequate intracellular access to faithfully reflect intracellular conditions. Finally, the often overlapping reactivities of reactive species with detection systems may hamper unequivocal identification and quantification of the responsible substance.

This review will focus on common approaches to detect oxidative stress as well as specific reactive oxygen and nitrogen species using methods and instrumentation commonly found in most research laboratories. Particular attention will be given to those approaches that use methods for the in vivo determinations of these reactive species.


    METHODS TO DETECT OXIDATIVE STRESS
 TOP
 ABSTRACT
 METHODS TO DETECT OXIDATIVE...
 SUPEROXIDE DETECTION
 DETECTION OF HYDROGEN PEROXIDE
 METHODS TO DETECT NO...
 DETECTION OF S-NITROSOTHIOLS BY...
 QUANTIFICATION OF 3...
 GRANTS
 REFERENCES
 
Reduction and Oxidation (Redox) Potential of the GSH/GSSG Couple: Indicator of Oxidative Stress in Vivo

Detoxification of reactive oxygen species is one of the prerequisites for all aerobic life forms, and multiple levels of enzymatic and nonenzymatic defenses have evolved to form what has been termed the oxidant defense network. An imbalance between these defense mechanisms and pro-oxidative forces in favor of the latter creates what has been termed "oxidative stress." Indeed, reduced glutathione (GSH) is recognized as one of the most important nonenzymatic oxidant defenses within the body. It exists in very large amounts (mM levels) within cells where it acts to detoxify peroxides as well as well as maintain other physiologically important antioxidants (e.g., {alpha}-tocopherol, ascorbic acid) in their reduced forms. Reduced glutathione is continuously regenerated from its oxidized form GSSG by the action of an NADPH-dependent reductase. Because the rates of synthesis of GSH, export of GSH and GSSG from the intracellular compartment to the extracellular space, and formation of protein-bound GSH mixed disulfides are slow relative to the rates of reduction of GSSG and oxidation of GSH, "the balance of GSH and GSSG provides a dynamic indicator of oxidative stress" in vivo (60). Indeed, alterations in tissue redox environment may reflect alterations in cell growth, differentiation, and apoptosis. Quantification of redox state of the GSH/GSSG pool in tissue and/or plasma that takes into account the correct stoichiometry of 2 GSH oxidized per GSSG formed may be determined by the redox potential (Eh), which is calculated according to the Nernst equation: Eh(mV) = Eo + 30 log([GSSG]/[GSH]2), where GSH and GSSG are molar concentrations and Eo is -264 mV for pH 7.4 (60). GSH and GSSG may be determined biochemically or by HPLC according to the method described by Jones (60). To avoid artifactual overestimation or underestimation of plasma GSH and GSSG, one must avoid hemolysis, limit oxidation, and inhibit the GSH degrading enzyme {alpha}-glutamyltranspeptidase. Because oxidation of thiols may occur rapidly on tissue disruption, it is essential that tissue be rapidly excised and freeze clamped or placed in liquid nitrogen prior to disruption (60).

Measurement of F2-Isoprostanes as Indicators of Lipid Peroxidation

Lipid peroxidation has been and remains one of the most widely used indicators of oxidant/free radical formation in vitro and in vivo. Unfortunately, many of the methods used to detect lipid peroxidation in urine, blood plasma, or tissue are nonspecific, relying on the detection of thiobarbituric acid (TBA)-reactive substances such as malondialdehyde (MDA) or other reactive aldehydes generated from the in vivo or ex vivo decomposition of lipid peroxidation products (102). In addition, it is well known that a variety of different bio-organic substances (e.g., bile acids, carbohydrates, nucleic acids, certain antibiotics, and amino acids) react with TBA to varying degrees, rendering this method sensitive but nonspecific (47). In 1990, Roberts and coworkers (88) discovered that nonenzymatic, free radical-induced lipid peroxidation produced F2-like prostanoid derivatives of arachidonic acid. Because these oxidized lipids are isomers of cyclooxygenase-generated prostaglandin F2{alpha}, they were termed F2-isoprostanes (IsoP). It had been known for many years that potent oxidants such as hydroxyl radical, peroxyl radicals, nitrogen dioxide, peroxynitrite, and higher oxidation states of heme and hemoproteins (ferryl heme) are capable of initiating peroxidation of polyunsaturated fatty acids (43). Roberts and Morrow (106) found that these types of oxidizing agents induced IsoP formation in vitro and in vivo as depicted in Fig. 1. Subsequent studies by this same group demonstrated that IsoPs are formed initially as esterified fatty acids attached to phospholipids and then are released to their free form by the action of phospholipases (106). There are several reasons why measurement of IsoP makes this approach one of the most reliable attractive markers for assessing oxidative stress in vivo. First, these compounds are stable and not produced by any known enzymatic pathways using arachidonate such as the cyclooxygenase or lipoxygenase pathways. In addition, IsoP levels can be quantified in extracellular fluids such as plasma and urine making this relatively noninvasive approach particularly useful for human and whole animal studies.



View larger version (23K):
[in this window]
[in a new window]
 
Fig. 1. Mechanisms of free radical-dependent formation of F2-isoprostanes from arachidonic acid (AA). A variety of potent oxidants such as hydroxyl radical, peroxyl radicals, nitrogen dioxide, peroxynitrite, and higher oxidation states of heme and hemoproteins (ferryl heme) initiate lipid peroxidation by abstracting allylic hydrogen atoms from polyunsaturated lipids such as arachidonatic acid. The resulting addition of oxygen to the lipid radicals followed by endocyclization and reduction results in the production of the F2-isoprostanes [adapted from Roberts et. al. (106)].

 

Another important consideration of IsoP detection is that these oxidized lipids increase in vivo in response to known free radical generators and oxidative stresses such as diquat or CCl4 administration (106). Furthermore, their enhanced production may be modulated by supplementation with different antioxidants including vitamin E and/or selenium (106). Finally, it has been confirmed that IsoP levels are not altered by lipid content in the diet. The major drawbacks of this approach relate to the detection systems required to quantify these oxidized lipids. Extensive analytic work has established that the most sensitive, reliable, and quantitative method for the detection of IsoPs is by mass spectrometry making the detection of IsoPs an expensive and time-consuming endeavor (106). Several commercially available ELISA kits have been developed for quantifying different IsoPs; however, there exists considerable interference with substances found in biological fluids and tissue extracts. It is highly recommended that samples be partially purified before analysis can be performed.

The above mentioned methods are used for the determination of generalized oxidative stress in vivo and in vitro. If one wishes to measure specific reactive oxygen species, there are additional methods, with varying degrees of applicability to the in vivo situation, available as described below.


    SUPEROXIDE DETECTION
 TOP
 ABSTRACT
 METHODS TO DETECT OXIDATIVE...
 SUPEROXIDE DETECTION
 DETECTION OF HYDROGEN PEROXIDE
 METHODS TO DETECT NO...
 DETECTION OF S-NITROSOTHIOLS BY...
 QUANTIFICATION OF 3...
 GRANTS
 REFERENCES
 
Cytochrome c Reduction

The reduction of ferricytochrome c to ferrocytochrome c has been used to measure rates of formation of superoxide by numerous enzymes, whole cells, and vascular tissue (3, 71, 82). At pH 8.5 and room temperature, the rate constant has been estimated at ~1.5 x 105 M/s (4, 4, 70)

The spectrophotometric reaction is followed at 550 nm; the extinction coefficient for ferricytochrome c is 0.89 x 104 M/cm, whereas that for ferrocytochrome c is 2.99 x 104 M/cm. Therefore, Em 550nm = 2.1 x 104 M/cm (82).

There are several precautions when using this reaction to detect superoxide. Reduction of cytochrome c is not absolutely specific for superoxide. Cellular reductants such as ascorbate and glutathione are capable of cytochrome c reduction and may be present in high concentration within tissue extracts, as are cellular reductases that enzymatically mediate cytochrome c reduction. Additionally, enzymes such as xanthine oxidase are capable of reducing quinones or redox-active dyes that may also be present and whose reduced forms are capable of directly reducing cytochrome c. It is important therefore to demonstrate specificity for superoxide of this reaction by the extent of inhibition of cytochrome c reduction by exogenous SOD (34).

Reduced cytochrome c can be reoxidized by cytochrome oxidases, cellular peroxidases, and oxidants, including hydrogen peroxide (H2O2) and peroxynitrite (ONOO-) (134). Because the apparent rate of cytochrome c reduction is decreased, these reoxidation reactions will underestimate the rate of superoxide formation. Enzyme inhibitors (10 µM CN for cytochrome oxidase) or scavengers of reactive species (100 U/ml catalase for H2O2, 10 mM urate for ONOO-) can be added to the reaction mixture to avoid this drawback.

To enhance the specificity of the cytochrome c assay for superoxide, cytochrome c can be acetylated (93). Acetylation of lysine residues present within ferricytochrome c decreases direct electron transfer by mitochondrial and microsomal reductases to cytochrome c and from cytochrome c by cytochrome oxidase, while maintaining superoxide's ability of to reduce cytochrome c (3). Succinoylation of cytochrome c is more effective in decreasing the reduction of cytochrome c by NADPH-cytochrome P-450 reductase or cytochrome b5 and oxidation by cytochrome c oxidase. However, succinoylation of cytochrome c decreases the rate constant of the reaction with superoxide by ~90% compared with native cytochrome c, thus requiring the use of higher concentrations of the succinoylated cytochrome c (69).

Because of size and charge considerations, cytochrome c has restricted intracellular access. This can reduce the value of the reaction when attempting to measure rates of superoxide formation within intact cells, as opposed to cellular or tissue extracts. Although the use of the cytochrome c reaction has achieved "gold standard" status for the detection of superoxide, particularly with in vitro assays and activated leukocytes, its relative insensitivity to detect low rates of superoxide formation, as well as interference by a variety of endogenous reductants, limits its applicability for in vivo detection. It has, however, been used to detect superoxide formation in vascular tissue (71).

Inhibition of Aconitase

Alterations in aconitase activity have been used as a sensitive index of changes in steady-state levels of superoxide in vitro and in vivo (36, 38, 49, 115, 140). Aconitase catalyzes the interconversion of citrate to isocitrate and is present in both cytosolic and mitochondrial forms. Superoxide inactivates aconitase due to oxidation followed by reversible loss of Fe from its cubane [4Fe-4S] cluster, with a rate constant of 106-107 M/s (19, 32, 48). Because of ongoing basal superoxide formation, a fraction of aconitase at any moment is inactive, but capable of reactivation; this ratio of inactive to active aconitase will increase as rates of superoxide production are augmented (36). Cell and tissue aconitase activity is thus determined by the relative rates of inactivation by superoxide or other oxidants, and the rate of reactivation by reduction and restoration of iron to the cluster (36, 49). Using this method, steady-state superoxide concentrations have been estimated at ~8-30 pM in A549 lung epithelial cells under normal conditions (86% active aconitase) and 50-200 pM in cells when 50% of aconitase is in the inactive form (38). Aconitase activity has been used to determine relative rates of superoxide formation in a variety of cell types including cultured neuronal cells, macrophages, and fibroblasts, as well as liver, heart, lung, and brain tissues (37, 85, 96).

Aconitase activity in cell or tissue homogenates is measured spectrophotometrically by following the conversion of isocitrate 20 mM to cis-aconitate at A240nm. A coupled assay where citrate serves as substrate for aconitase and the isocitrate product is then converted to {alpha}-ketoglutarate by NADP+-dependent isocitrate dehydrogenase allows monitoring of NADPH formation at A340nm and can diminish background absorbance interference. Reactivation of aconitase activity can be accomplished by addition of the reducing agent dithiothreitol, ferrous ammonium sulfate, and Na2S to cellular extracts and remeasuring aconitase activity (49).

Other oxidants, in addition to superoxide, can modify aconitase activity. Peroxynitrite will oxidize the [4Fe-4S] cluster of the enzyme with subsequent loss of activity, which is restored by the addition of thiol reagents and reduced iron (19, 48). The rate constant of this bimolecular reaction has been estimated at 105 M/s. (19) It has also been reported that NO itself can inhibit aconitase activity, but it is unclear whether, in vivo, NO is directly responsible for significant enzyme inactivation or it is the result of ensuing ONOO- formation. The effect of NOS inhibition on extents of aconitase inactivation may help to determine the role(s) of superoxide and NO-derived species in enzyme inactivation. Oxygen and H2O2 have also been noted to inhibit aconitase activity, albeit with rate constants four to five orders of magnitude lower than those noted for superoxide or ONOO- so that a direct contribution of oxygen and H2O2 to oxidant-mediated aconitase inactivation is minimal (32).

Hydroethidine Oxidation by Superoxide

Hydroethidine (dihydroethidium, HE) is a cell-permeant compound that can undergo a two-electron oxidation to form the DNA-binding fluorophore ethidium bromide or a structurally similar product (8, 143). The reaction is relatively specific for superoxide, with minimal oxidation induced by H2O2 or hypochlorous acid (HOCl) (8). The intracellular oxidation of HE to ethidium by superoxide has been analyzed with flow cytometry in cell suspensions (18), and visualization of cellular and anatomic regions displaying increased rates of oxidant production with digital imaging microfluorometry has been described in vivo (126) and in tissue slices and isolated blood vessels (9, 87). In contrast to other "intracellular" probes for superoxide, such as lucigenin, there is little capacity for artifactual formation of superoxide by HE due to redox cycling. However, there are critical reactions that may limit the use of HE conversion to ethidium as a quantitative marker for superoxide production (8). First, cytochrome c is also capable of oxidizing HE—this may be of importance 1) when mitochondria are the primary source of superoxide production or 2) when cytochrome c is released into the cytosol under conditions leading to apoptosis (42). Because oxidant stress has been suggested to initiate apoptotic processes and apoptosis itself has been proposed to increase mitochondrial superoxide production (17), it would be difficult to ascribe HE conversion to ethidium solely to superoxide; thus localization of cellular sites of superoxide generation would be suspect under these circumstances. Furthermore, use of high concentrations of HE can result in superoxide-independent fluorescence as a result of ethidium formation that exceeds the binding capacity of mitochondrial nucleic acids, allowing the ethidium cation to bind to nuclear DNA with marked enhancement of fluorescence (15). Quantitation of superoxide production using HE may also be inaccurate due to its capacity to enhance rates of superoxide dismutation to H2O2 (8). Thus, under these conditions, initial rates of superoxide formation will be underestimated. Finally, as with the use of any fluorophore for tissue localization of the compound of interest, the potential for autofluorescence must be recognized and taken into account (120). Because of these considerations, the use of HE for the determination of superoxide in vivo appears to have significant limitations.

Chemiluminescence Reactions

Chemiluminescent methods for superoxide detection have been frequently employed because of the potential for access to intracellular sites of superoxide generation, the alleged specificity of reaction of the chemiluminescent probe with superoxide, minimal cellular toxicity, and increased sensitivity when compared with chemical measurements. The most widely used chemiluminescent compound for superoxide detection is lucigenin. However, the potential for redox cycling of lucigenin and artifactual generation of superoxide have raised questions concerning its appropriate use for determining quantitative rates of superoxide formation (75, 130). Although it has been suggested that reducing the concentration of lucigenin to 5 µM will eliminate the potential for redox cycling (89, 118), other investigations have demonstrated that redox cycling with increased oxygen consumption and enhanced formation of superoxide occurs at this concentration (5, 58). Interestingly, the presence of different electron donors (NADH vs. NADPH) in the reaction mixture influences both lucigenin-dependent redox cycling and chemiluminescent intensities (58). Despite its limitations in precisely estimating rates of superoxide formation, the use of low concentrations of lucigenin can be useful in providing qualitative information concerning the involvement of superoxide in a given experimental condition.

In an effort to make use of the advantages of chemiluminescent techniques, other nonredox-cycling compounds have been studied for their utility as probes for superoxide. Coelenterazine [2-(4-hydroxybenzyl)-6-(4-hydroxyphenyl)-8-benzyl-3,7-dihydroimidazo [1,2-{alpha}] pyrazin-3-one] is a lipophilic luminophore originally isolated from the coelenterate Aequorea and is the light-producing chromophore in the aequorin complex (90, 91, 116, 132). Superoxide-stimulated chemiluminescence occurs after direct oxidation of coelenterazine (39, 132), thus eliminating the redox cycling-dependent artifactual generation of superoxide that generates controversy with lucigenin (75, 132, 137). Although the intensity of light emitted from the interaction of coelenterazine with superoxide is greater than lucigenin-dependent chemiluminescence, coelenterazine-dependent chemiluminescence is not entirely specific for superoxide, as ONOO- will also result in luminescence in the presence of coelenterazine (131). Selective use of NOS inhibitors, as well as ONOO- scavengers, may aid in discriminating between the contributions of superoxide and ONOO- to chemiluminescence under these circumstances. In addition to in vitro chemical assays, coelenterazine-dependent chemiluminescence has been used in cultured cells (25), neutrophils (77), vascular tissues (51, 121, 131), and isolated mitochondria (104). Structural analogs, CLA [2-methyl-6-phenyl-3,7-dihydroimidazo[1,2-{alpha}] pyrazin-3-one] and MCLA [2-methyl-6-(4-methoxyphenyl)-3,7-dihydroimidazo[1,2-{alpha}] pyrazin-3-one] have also been used to assess superoxide formation in a variety of conditions, including neutrophil and macrophage activation (92, 125), cultured cells (57, 129), and vascular tissue (117). Of note, with the use of MCLA chemiluminescence, in vivo superoxide production has been reported from the surface of liver (135), intestine (114), heart (136), and lung (77, 91, 127).

Electron Spin Resonance and Spin Trapping

Electron spin resonance (ESR) spectroscopy, also known as electron paramagnetic resonance (EPR), is at present the only analytic approach that permits the direct detection of free radicals. This technique reports on the magnetic properties of unpaired electrons and their molecular environment. Unpaired electrons can exist in two orientations, either parallel or anti-parallel with respect to an applied magnetic field. The energy differences of these states correspond to the microwave region of the electromagnetic spectrum. While the unpaired electrons of species such as NO, superoxide, and hydroxyl radical (·OH) are too low in concentration and short lived to be directly detected by ESR in biological systems, this dilemma can be avoided by ESR measurement of more stable secondary radical species. For superoxide this generally consists of converting short-lived oxygen centered adducts to longer-lived carbon adducts.

These more stable radical species are formed by adding exogenous "spin traps"—molecules that react with primary radical species to give more enduring radical adducts, with characteristic ESR "signatures." These spin traps, frequently nitroxide and nitrone derivatives, can also be used to label biomolecules and probe basal and oxidative-induced molecular events in protein and lipid microenvironments (10, 139). With a limit of sensitivity of ~10-9 M, ESR spectroscopy is capable of detecting the more stable free radical-derived species produced during oxidative and inflammatory injury, including ascorbyl radical, tocopheroxyl radical, and heme-nitrosyl complexes (73). The use of spin traps such as phenyl-tert-butylnitrone (PBN) and 5,5-dimethylpyrroline-N-oxide (DMPO) have had an illustrious history in detecting organic radical products of lipid peroxidation (PBN), ·OH, and superoxide (DMPO). However, uncertainties about influences on NO metabolism (PBN) and the ability of ferric ion to oxidize DMPO resulting in the classic four-line spectrum associated with ·OH metabolism (79), has led to development of more selective species. Recently, a more superoxide-specific and stable spin trap, 5-diethoxyphosphoryl-5-methyl-1-pyrroline-N-oxide (DEPMPO) (33, 111), has proven useful in measuring extents of superoxide production cell and tissue extracts (23, 138). However, in the presence of tissue reductants, such as ascorbate, the nitrone ESR-active adducts can be rapidly reduced to ESR silent species and may lead to underestimation of the rates of formation of reactive species. Cyclic hydroxylamines such as 1-hydroxy-3-carboxy-pyrrolidine are oxidized by superoxide or ONOO- to form stable radical adducts that can be detected by ESR and these adducts are less reactive to cellular reductants such as ascorbate and glutathione (24), suggesting their potential utility in measuring reactive species production in intact cells. Reactive species have been successfully detected in vivo with ESR (35, 50, 103). Although probe instability, tissue metabolism, lack of spin trap specificity, and the cost of ESR spectrometers makes this technique less than ideal for the in vivo determination of free radicals, one may enhance the dependability of this technique by combining it with other strategies for detecting specific reactive species (see above and below).


    DETECTION OF HYDROGEN PEROXIDE
 TOP
 ABSTRACT
 METHODS TO DETECT OXIDATIVE...
 SUPEROXIDE DETECTION
 DETECTION OF HYDROGEN PEROXIDE
 METHODS TO DETECT NO...
 DETECTION OF S-NITROSOTHIOLS BY...
 QUANTIFICATION OF 3...
 GRANTS
 REFERENCES
 
Horseradish Peroxidase-Linked Assays

Numerous assays for the detection of H2O2 depend on the oxidation of a detector compound. In the presence of H2O2, hydrogen donors are oxidized by HRP (11)

The amount of H2O2 present is estimated by following the decrease in fluorescence of initially fluorescent probes such as scopoletin (7-hydroxy-6-methoxy-coumarin) (12) or by monitoring the increase in fluorescence from previously nonfluorescent hydrogen donors such as diacetyldichlorofluorescin (52), p-hydroxyphenylacetate (54), homovanillic acid (3-methoxy-4-hydroxyphenylacetic acid) (113), or Amplex Red (N-acetyl-3,7-dihydroxyphenoxazine) (21, 144). Oxidation of tetramethylbenzidine (124) or phenol red (100) can be followed spectrophotometrically using the same principle. Several precautions are required for accurate interpretation of reporter molecule test systems for detection of H2O2 in biological systems.

Numerous biological compounds including thiols and ascorbate can serve as substrate for horseradish peroxidase (HRP) and thus compete with the detector molecule for oxidation, leading to underestimation of H2O2 formation.

Competition with HRP by endogenous catalase for H2O2 can also lead to underestimation of H2O2. For example, in the scopoletin-HRP coupled assay, rates of H2O2 formation in isolated mitochondria or submitochondrial particles ranged from 2 to 76% of those detected by either oxygen consumption or by H2O2-induced cytochrome c peroxidase Compound I formation. Quenching of fluorescent signals by cell and tissue components can lead to overestimation of H2O2 in the case of scopoletin or underestimation, as with homovanillic acid. When measuring cellular or subcellular H2O2 accumulation, accuracy of the assay can be improved by separation of the incubation media from cellular components before addition of the detection system, thus limiting confounding interactions of the detection system with cellular elements (124).

Spectrophotometric assays using HRP-coupled reactions also have limitations. Direct reduction of the oxidized detector molecule by electron transport components can limit the utility of tetramethylbenzidine in H2O2 determination, e.g., in mitochondria (124). Although spectrophotometric detection of H2O2 with phenol red has been used successfully in purified enzyme-substrate mixtures and to detect H2O2 release from activated leukocytes (100), the phenol red-HRP assay is exquisitely pH dependent and less sensitive than fluorescent methods, reducing its utility when attempting to detect H2O2 from cell types with low endogenous rates of oxidant formation. Taken together, the HRP-linked assays represent a particularly useful method for the quantification of H2O2 levels in cultured cells, organ cultures, and isolated buffer perfused tissue preparations. However, these methods are not suitable for determinations of H2O2 in plasma or serum because many reducing agents present in extracellular fluid (e.g., GSH, ascorbate, etc.) will interfere with the assay.

Dichlorofluorescein Fluorescence

The oxidation of 2'-7'-dichlorofluorescin (DCFH) to the fluorescent compound 2'-7'-dichlorofluorescein (DCF) was initially thought to be a relatively specific indicator of H2O2 formation (63) and has been used extensively in the detection of oxidants produced during the respiratory burst in inflammatory cells, either in cell lysates or in intact cells using flow cytometry (6, 97). The diacetate form of DCFH (DCFH-DA) is taken up by cells, where DCFH-DA is metabolized by intracellular esterases to DCFH, which has been suggested to remain "trapped" intracellularly. In the presence of H2O2, DCFH is oxidized to DCF; fluorescence is measured with excitation at 498 nm and emission at 522 nm. However, there are limitations to the interpretation of DCF fluorescence as a specific marker for quantitative intracellular H2O2 formation.

The H2O2-dependent oxidation of DCFH to DCF occurs slowly, if at all, in the absence of ferrous iron (110). Furthermore, DCF formation is greatly enhanced in the presence of heme-containing substances such as hematin, peroxidases, or cytochrome c or other redox-active metal ions (20, 53, 74, 110). Critically, peroxidases are capable of inducing DCFH oxidation in the absence of H2O2 (72, 74, 108). Thus alterations in cellular peroxidase or heme activity are likely to be equally if not more important than H2O2 in determining rates of DCF formation and cellular fluorescence (16, 94). Furthermore, a recent report emphasizes the critical role that intracellular iron trafficking plays in mediating H2O2-dependent DCF fluorescence (128).

Intracellularly formed DCFH does not necessarily remain within the confines of the intracellular space, but rather can reaccumulate in extracellular media where it would be available for reaction with extracellular oxidants (112).

The peroxidase-dependent formation of DCF from DCFH, both in the presence and absence of H2O2, is complex and generates both the DCF semiquinone free radical (108), the DCF phenoxyl radical DCF· (109), as well as superoxide. The dismutation of superoxide to H2O2 would then yield artifactual DCFH oxidation and amplification of DCF fluorescence.

In addition to peroxidase-dependent oxidation of DCFH, other substances are capable of directly inducing DCF formation in the absence of H2O2, including ONOO- and HOCl (22, 68). Lipid peroxides are also capable of inducing DCF fluorescence in the presence of heme-containing compounds (20).

A structurally related analog of DCFH is dihydrorhodamine 123 (DHR), a cell-permeant, mitochondrial-avid compound that is oxidized to the fluorophore rhodamine 123. Although a direct reaction of DHR 123 with H2O2 does not occur, it can be catalyzed by heme-containing peroxidases such as HRP (74) or other heme compounds, including cytochrome c. (112) However, several other cell-derived oxidants such as ONOO- and HOCl are also capable of directly oxidizing DHR 123 (22). Although careful application of SOD, catalase, and ONOO- scavengers may provide more precise identification of the substance(s) responsible for DHR oxidation, in many instances, several of these compounds may be produced concomitantly, resulting in multiple pathways responsible for the oxidation of DHR 123 to rhodamine within the cellular milieu.

Because of the various biologic substances that can lead to DCF and rhodamine fluorescence and the inherent uncertainty relating to endogenous vs. artifactual oxidant generation, these fluorescent assays are probably best applied as qualitative markers of cellular oxidant stress, rather than as precise indicators of rates of H2O2 formation for in vitro and in vivo systems.

Aminotriazole Inhibition of Catalase

A major pathway for clearance of H2O2 is through reaction with catalase. The intermediate complex, Compound I, that is formed in catalase-dependent metabolism of H2O2 is relatively stable. Aminotriazole, an irreversible inhibitor of catalase, reacts with the Compound I intermediate; thus catalase is inhibited by aminotriazole only in the presence of H2O2 (80). Intracellular rates of production of H2O2 can therefore be estimated by determining the half time of aminotriazole-dependent inactivation of catalase; steady-state H2O2 concentration can be approximated according to (65, 95)

This method has in fact been used to assess rates of H2O2 formation in numerous isolated cell types as well as in vivo (45, 99, 142). It should be remembered, however, that under conditions where glutathione peroxidase-reductase significantly contributes to H2O2 metabolism, this method will underestimate actual H2O2 concentrations (65).


    METHODS TO DETECT NO AND ITS DECOMPOSITION PRODUCTS IN VIVO
 TOP
 ABSTRACT
 METHODS TO DETECT OXIDATIVE...
 SUPEROXIDE DETECTION
 DETECTION OF HYDROGEN PEROXIDE
 METHODS TO DETECT NO...
 DETECTION OF S-NITROSOTHIOLS BY...
 QUANTIFICATION OF 3...
 GRANTS
 REFERENCES
 
More than 20 years ago it was demonstrated that rodents and humans excrete much larger amounts of nitrate () than could be accounted for by ingestion of food. Subsequent studies revealed that germ-free rats also excreted significantly more than could be accounted for by dietary ingestion, suggesting that mammalian cells have the biochemical machinery necessary to synthesize oxidized metabolites of nitrogen. Subsequent studies from several disciplines converged to identify NO as the precursor of and an important regulatory molecule involved in regulation of the immune, cardiovascular, and nervous systems. It has been known for many years that NO is relatively unstable in the presence of molecular O2 and will rapidly and spontaneously autoxidize to yield a variety of nitrogen oxides

where NO2, N2O3, and represent nitrogen dioxide, dinitrogen trioxide, and nitrite, respectively. It has been definitively demonstrated that the only stable product formed by the spontaneous autoxidation of NO in oxygenated solutions is . However, when one analyzes urine or plasma, predominantly is found in these extracellular fluids. Although the mechanisms by which NO is converted to in vivo are not entirely clear, there are at least two possibilities. One mechanism, proposed by Ignarro et al. (56), suggests that the derived from NO autoxidation is rapidly converted to via its oxidation by certain oxyhemoproteins (P-Fe2+O2) such as oxyhemoglobin or oxymyoglobin

or

It should be noted, however, that these investigators used large concentrations of NO (300 µM), which will rapidly autoxidize to . Although the authors suggested that the would in turn react with the hemoproteins, this reaction is quite slow, requiring 2-3 h. A second, possibly more reasonable explanation for the presence of predominately in vivo may have to do with the fact that the levels of NO produced by NO synthase (NOS) in vivo would be much smaller and thus the half-life of NO would be much longer. In this case, NO would react directly and very rapidly with oxyhemoproteins to yield before it has an opportunity to autoxidize to . It should be noted that saliva does contain relatively high concentrations of , which many investigators suggest is synthesized by the oral bacteria.

Approximately 56% of the human body is fluid. Although most of the fluid is localized within the intracellular compartment (intracellular fluid), ~30% of the total body water is found in the spaces outside the cells and is termed extracellular fluid. Examples of some extracellular fluids include plasma, lymph, urine, cerebrospinal fluid (CSF), intraocular fluid, sweat, and tears, as well as a variety of gastrointestinal fluids, including salivary, gastric, intestinal, pancreatic, and biliary secretions. Extracellular fluids such as plasma, lymph, and CSF are continuously being transported via the circulation to all parts of the body. This rapid transport and subsequent mixing between the plasma and extracellular fluid via diffusion through the capillary endothelial cells allows all cells in the body to be exposed to essentially the same extracellular environment. Thus the presence of certain metabolites in extracellular fluid provides a good indicator for those metabolic processes that occur at the cellular and tissue level. Furthermore, because some extracellular fluids (e.g., urine, saliva, tears) are normally excreted, these fluids may be collected and metabolites analyzed in a noninvasive manner, thereby allowing the continuous determination of systemic levels of various metabolites. One metabolite that has been known to be present in plasma and urine is nitrate (). Because saliva and lymph also contain substantial amounts of nitrite () and , one would predict that other fluids, such as CSF, bile, tears, sweat, and intraocular fluid also contain this low molecular weight metabolite.

The methods outlined below describe methods to quantify and in extracellular fluids such as plasma, urine, and/or lymph. The same methods may also be used for other extracellular fluids (e.g., saliva, tears, etc.), cell culture fluid, and/or organ culture supernatants

Preparation of Extracellular Fluids: Complications and Considerations

Determination of urinary or plasma levels of and provides a useful method to quantify systemic NO production in vivo. Analysis of urine for the presence of nitrogen oxides remains one of the easiest methods to assess noninvasively systemic NO metabolism. It should be remembered that urinary (or plasma) levels reflect not only endogenous NO production but also total ingestion from the diet as well as the minor contribution made by bacteria found in the gut. Thus animals should either be fasted or allowed to ingest -free diets before determinations. It has been our experience that a 24-h fast will reduce plasma levels by 60-80%, demonstrating that the majority of the circulating nitrate in rats is contributed to their diet. Furthermore, it is important to include "antibiotics," such as propanol or penicillin/streptomycin in collection tubes, to prevent bacterial growth during collection (41).

The collection and processing of plasma and lymph also require some precaution. We have found the heparinized plasma or lymph may form a precipitate on addition of the highly acidic Griess reagent, rendering these samples unusable for analysis (44). Interestingly, the precipitation does not occur in all samples and will occasionally occur even when protein is first removed by addition of ZnSO4 or ultrafiltration. Because of these inconsistent results it has been difficult to determine the mechanism of this precipitation reaction. We determined that the presence of heparin may promote precipitation of the plasma or lymph samples when acidified by the Griess reagent. We propose that the inability to produce consistent precipitation in all samples may be the result of the small but significantly different amounts of heparin used for each sample, as the volume of heparin is never accurately measured when using this anticoagulant. We have found that the use of citrate as an anticoagulant or allowing plasma to clot to yield serum completely prevents this problem. We have also determined that when the need arises to assess plasma or lymph and levels in heparinized fluid, we can do so if the heparin is removed using protamine sulfate precipitation before the addition of the Griess reagent.

Determination of Nitrate and Nitrite Using the Griess Reaction

One method for the indirect determination of NO involves the spectrophotometric measurement of its stable decomposition products and . This method requires that first be reduced to and then determined by the Griess reaction as shown in Fig. 2. Briefly, the Griess reaction is a two-step diazotization reaction in which the NO-derived nitrosating agent (e.g., N2O3), generated from the acid-catalyzed formation of nitrous acid from nitrite (or the interaction of NO with oxygen), reacts with sulfanilic acid to produce a diazonium ion that is then coupled to N-(1-napthyl)ethylenediamine to form a chromophoric azo product that absorbs strongly at 543 nm (44). For quantification of and in extracellular fluids, we have found enzymatic reduction of to using a commercially available preparation of nitrate reductase (NR) to be the most satisfactory method (44)



View larger version (16K):
[in this window]
[in a new window]
 
Fig. 2. The Griess reaction. The nitrosating agent dinitrogen trioxide (N2O3) generated from the autoxidation of nitric oxide (NO) or from the acidification of nitrite (NO2-) reacts with sulfanilamide to yield a diazonium derivative. This reactive intermediate will interact with N-1-naphthylethylene diamine to yield a colored diazo product that absorbs strongly at 540 nm.

 

Aspergillus NR (Boehringer Mannheim, Indianapolis, IN) is highly efficient at reducing very small amounts of to . After the incubation, any unreacted NADPH is oxidized by addition of lactate dehydrogenase and pyruvic acid because reduced pyridine nucleotides (NADPH, NADH) strongly inhibit the Griess reaction. An alternative method for oxidizing any unreacted NADPH is to replace the LDH/pyruvate system with 1 mM potassium ferricyanide (44). A known volume of premixed Griess reagent is then added to each incubation mixture and incubated for 10 min, and the absorbance of each sample was determined at 543 nm.

As mentioned previously, we found that the presence of heparin in plasma or lymph sample may produce precipitation on addition of the Griess reagent. Therefore, heparin must be removed before the addition of the Griess reagent using addition of a small aliquot of protamine sulfate as previously described (44).

Determination of NO Using Fluorescence Spectroscopy

Diaminonaphthalene assay. Although the Griess reaction is a simple, rapid, and inexpensive assay for and in physiological fluids, it has a practical sensitivity limit only 2-3 µM. In attempts to enhance the sensitivity of measuring or NO generated under physiological conditions, different fluorimetric methods have been developed that exploit the ability of NO to produce N-nitrosating agents. One of these methods employed the use of the aromatic diamino compound 2,3-diaminonaphthalene (DAN) as an indicator of NO formation (86). The relatively nonfluorescent DAN reacts rapidly with the NO-derived N-nitrosating agent (N2O3) generated from the interaction of NO with oxygen or from the acid-catalyzed formation of nitrous acid from nitrite to yield the highly fluorescent product 2,3-naphthotriazole (NAT; Fig. 3). This assay offers the additional advantages of specificity, sensitivity, and versatility. This assay is capable of detecting as little as 10-30 nM (i.e., 10-30 pmol/ml) NAT and may be used to quantify NO generated under biologically relevant conditions (e.g., neutral pH) with minimal interference by nitrite decomposition (86). As with the Griess reaction, the DAN assay can be used to quantify NO production at under physiological conditions and/or stable decomposition products of NO in physiological fluids as well as tissue culture media and organ culture supernatants.



View larger version (18K):
[in this window]
[in a new window]
 
Fig. 3. Fluorometric detection of NO or nitrite using diaminonaphthalene (DAN). The nitrosating agent dinitrogen trioxide (N2O3) generated from the autoxidation of NO or from the acidification of nitrite (NO2-) reacts with DAN to yield the highly fluorescent product naphthotriazole (NAT).

 

Diaminofluoroscein-2 assay. In addition to the DAN assay, more recent studies demonstrated that diaminofluoroscein-2 (DAF-2) may be used to determine the presence of NO in vitro and in situ (66, 67). Like DAN, nitrosation of the diamino group results in a nitrosamine that, through an internal rearrangement, forms the fluorescent triazole (Fig. 4). The advantages of this compound are that wavelength associated with fluorescien can be used, making equipment currently used for other bioassays as well as cell and tissue imaging easily adapted to detect NO in vitro and in vivo. Although NO-derived N2O3 is to be the primary mechanism by which cells and tissue generate the triozole derivative, recent investigations suggest that oxidative nitrosation may represent an alternative pathway for triazole generation (29, 31). This implies that, under biological conditions, the triazole can be formed from either nitrosative or oxidative chemistry.



View larger version (17K):
[in this window]
[in a new window]
 
Fig. 4. Fluorometric detection of NO using diaminofluroscein-2 diacetate (DAF-2 DA). DAF-2 DA diffuses into cells and tissue where nonspecific esterases hydrolyze the diacetate residues thereby trapping DAF-2 within the intracellular space. NO-derived nitrosating agents such as N2O3 nitrosate DAF-2 to yield its highly fluorescent product DAF-2 triazole (DAF-2 T).

 

In solution or media these two pathways can be differentiated. The use of nitrosative scavengers such as azide will prevent nitrosation but not oxidation. Conversely, urate will quench oxidative nitrosation but not nitrosative nitrosation. Using different scavengers, the chemistry of DAF-2 formation can teased out in different experiments (29, 31). Although DAF-2 has been thought to be an indicator of NO, it recently has been shown that nitroxyl (HNO) reacts with DAF-2 giving even higher yields of triazole than NO (30). In light of the potential for HNO in biological systems, it could be interesting to entertain the possibility that some of the NO detected by DAF-2 is in fact HNO. One cautionary note is that using powerful light sources such as lasers can result in photochemistry that can lead to false positives. It should be noted that control tests need to be done to ensure that it is the chemistry from NO and not some artifact of the photochemistry.


    DETECTION OF S-NITROSOTHIOLS BY COLORIMETRIC AND FLUOROMETRIC METHODS
 TOP
 ABSTRACT
 METHODS TO DETECT OXIDATIVE...
 SUPEROXIDE DETECTION
 DETECTION OF HYDROGEN PEROXIDE
 METHODS TO DETECT NO...
 DETECTION OF S-NITROSOTHIOLS BY...
 QUANTIFICATION OF 3...
 GRANTS
 REFERENCES
 
The formation and biological properties of NO-derived S-nitrosothiols (RSNOs) play an important part of the biology of NO (2, 122, 123). It is well appreciated that autoxidation of NO in the presence of thiols (RSH) generates RSNOs via the following mechanism

Different RSNOs are known to stimulate guanylate cyclase thereby promoting vasorelaxation. Although controversial, studies have also proposed that S-nitrosohemoglobin adducts are involved in homeostasis of vascular tone and oxygen delivery (40, 59). Furthermore, the S-nitrosation of proteins has been suggested as an important step in cell signaling as well as inhibition of a variety of enzymes. Here we describe methods for the colorimetric and fluorometric detection of RSNO (141).

The detection of RSNO has often employed the Saville reaction, which involves the displacement of the nitrosonium ion (NO+) by mercury salts (Fig. 5). The resulting nitrite or NO generated from the spontaneous decomposition of NO+ is detected by methods such as chemiluminescence or HPLC. These methods involve equipment and expertise not always found in most laboratories. Other techniques for the detection of RSNO employ colorimetric methods such as the Griess reaction to measure the nitrite formed from the treatment of RSNO with mercuric chloride. However, samples that contain large amounts of nitrite can interfere with and limit the detection range of these methods under acidic conditions. To overcome these problems, two methods have been devised to detect RSNO-derived nitrosating species at neutral pH (141). The colorimetric method uses the components of the Griess reaction while the fluorimetric method uses the conversion of DAN to its fluorescent triazole derivative (141). These methods may be conducted at neutral rather than acidic pH, which eliminates the interference of contaminating nitrite and allows the detection of nitrosation mediated by the presence of NO.



View larger version (16K):
[in this window]
[in a new window]
 
Fig. 5. Detection of S-nitrosothiols (RSNO) by the Saville reaction. Liberation of the nitrosating specie nitrosonium (NO+) by interaction of RSNO with mercury salts in the presence of the Griess reagents, results in the formation of the same diazo product as described in Fig. 2.

 

The colorimetric reaction uses the same chemistry as described previously in which the nitrosating specie nitrosonium (NO+) generated from the interaction between RSNO and mercuric chloride interacts with sulfanilamide to form a diazonium ion (Fig. 5). The resulting diazonium salt then reacts with naphthylethylenediamine to form the colored azo complex (Fig. 4). The fluorometric assay is based on the reaction of DAN with NO+ liberated from RSNO after mercuric chloride addition to yield a primary nitrosamine, which is converted rapidly to a fluorescent triazole (Fig. 6). The colorimetric assay has a detection range of 0.5-100 µM, while the fluorometric assay is effective in the range of 50-1,000 nM RSNO (141). The combination of the two assays provides a detection range from 50 nM to 100 µM RSNO, required for most biological experiments. Variations of these methods have been used successfully to quantify high and low molecular weight RSNOs in human and rat plasma as well as the S-nitrosated derivatives of human and rat hemoglobin (61, 62).



View larger version (15K):
[in this window]
[in a new window]
 
Fig. 6. Fluorometric detection of RSNO. Liberation of nitrosonium (NO+) by interaction of RSNO with mercury salts in the presence of the DAN results in the formation of the same fluorometric triazole derivative described in Fig. 3.

 


    QUANTIFICATION OF 3-NITROTYROSINE: SPECIFIC FOOTPRINT FOR PEROXYNITRITE?
 TOP
 ABSTRACT
 METHODS TO DETECT OXIDATIVE...
 SUPEROXIDE DETECTION
 DETECTION OF HYDROGEN PEROXIDE
 METHODS TO DETECT NO...
 DETECTION OF S-NITROSOTHIOLS BY...
 QUANTIFICATION OF 3...
 GRANTS
 REFERENCES
 
NO may rapidly interact with the free radical to yield the potent oxidants peroxynitrite (ONOO-) and its conjugate acid peroxynitrous acid (ONOOH) (7)

Although a tremendous number of investigations have been performed that suggest that ONOO- may play an important role in several pathophysiological situations, the question of whether ONOO- is actually formed in vivo and exerts any physiological and/or pathophysiological activity remains the subject of vigorous debate. Because it has been reported that only ONOO- will nitrate tyrosine residues in proteins and peptides under physiological conditions, the presence of nitrotyrosine (NT) has been used as evidence for ONOO production in vivo. Indeed, the vast majority of studies implicating ONOO- as an important cytotoxic specie have used immunohistochemical or HPLC determinations of NT as proof of ONOO- formation in vivo. In reality, NT may be generated by multiple pathways suggesting that the presence of NT is not a specific "footprint" for ONOO- formation in vivo (Fig. 7). For example, work by several laboratories demonstrated that tyrosine can be nitrated by peroxidase (or heme)-catalyzed, hydrogen peroxide-dependent oxidation of nitrite to form NO2 (Fig. 6) (28, 133)



View larger version (14K):
[in this window]
[in a new window]
 
Fig. 7. Multiple pathways for the formation of 3-nitrotyrosine. 3-Nitrotyrosine may be generated by peroxynitrite (ONOO-), autoxidation of NO, nitroxyl (HNO) in the presence of oxygen, heme, or hemoprotein catalyzed, H2O2-dependent oxidation of nitrite (), interaction with HOCl, and acidified .

 

It has been shown that MPO and other peroxidases will mediate this reaction. Colocalization of these peroxidases with NT strongly indicates this reaction is the primary source of tyrosine nitration in vivo (26). Although some studies have indicated the possibility of peroxidase-independent sources of NT formation (14), it should be remembered that virtually any hemoprotein (e.g., hemoglobin, myoglobin, cytochromes) possesses the potential to catalyze the H2O2-dependent oxidation of nitrite to yield NT (64). In addition to heme or hemoprotein-mediated NT formation, the MPO-derived oxidant hypochlorous acid (HOCl) will interact with nitrite to yield the potent nitrating agent nitryl chloride (Cl-NO2), which, in and of itself, will nitrate tyrosine to form NT (27).

Another example of ONOO--independent generation of NT is the reaction of tyrosine with acidified nitrite

When the pH approaches 4-5, nitrite can slowly generate NT (101). Whether acidified nitrite can produce NT in vivo remains the subject of active investigation. It is possible that this reaction may be important in acidic microenvironments such as the lipid bilayer, phagolysosomes, etc., where NO accumulation and oxidation to nitrite would readily occur.

It has been found that the autoxidation of NO can also generate NT (98). Although possible in free solution, nitration via the autoxidation of NO (i.e., the NO/O2 reaction) occurs optimally only with supraphysiological fluxes of NO (i.e., 1 mM), suggesting that this mechanism most probably does not occur in vivo in cell cytosol or extracellular fluid (98). However, it should be remembered that NO (and O2) are known to concentrate to very large amounts within the lipid bilayer, suggesting that the autoxidation of NO in this hydrophobic environment would produce NO2 and N2O3 that would readily form NT (76).

Finally, interaction of tyrosine with nitroxyl (HNO) may represent a potential pathway for NT in vivo. It has been demonstrated that HNO combines with oxygen to form a peroxynitrite like species (87a, 87b). However, unlike peroxynitrite, this oxidant will not nitrate the amino acid tyrosine (94a). However, exposure to large concentrations of HNO donor can result in nitrated protein. The mechanistic differences are still being addressed and represent a possible HNO source, although probably only under specific conditions.


    GRANTS
 TOP
 ABSTRACT
 METHODS TO DETECT OXIDATIVE...
 SUPEROXIDE DETECTION
 DETECTION OF HYDROGEN PEROXIDE
 METHODS TO DETECT NO...
 DETECTION OF S-NITROSOTHIOLS BY...
 QUANTIFICATION OF 3...
 GRANTS
 REFERENCES
 
This research was supported by National Heart, Lung, and Blood Institute Grants HL-66110 (to M. M. Tarpey) and National Institute of Diabetes and Digestive and Kidney Diseases Grants DK-43785 and DK-64023 (to M. B. Grisham) and by the Broad Medical Research Foundation (to M. B. Grisham).


    FOOTNOTES
 

Address for reprint requests and other correspondence: M. B. Grisham, Dept. of Molecular and Cellular Physiology, LSU Health Sciences Center, 1501 Kings Highway, Shreveport, LA 71130 (E-mail: mgrish{at}lsuhsc.edu).


    REFERENCES
 TOP
 ABSTRACT
 METHODS TO DETECT OXIDATIVE...
 SUPEROXIDE DETECTION
 DETECTION OF HYDROGEN PEROXIDE
 METHODS TO DETECT NO...
 DETECTION OF S-NITROSOTHIOLS BY...
 QUANTIFICATION OF 3...
 GRANTS
 REFERENCES
 

  1. Abrahamsson T, Brandt U, Marklund SL, and Sjoqvist PO. Vascular bound recombinant extracellular superoxide dismutase type C protects against the detrimental effects of superoxide radicals on endothelium-dependent arterial relaxation. Circ Res 70: 264-271, 1992.[Abstract/Free Full Text]
  2. Arnelle DR and Stamler JS. NO+, NO, and NO- donation by S-nitrosothiols: implications for regulation of physiological functions by S-nitrosylation and acceleration of disulfide formation. Arch Biochem Biophys 318: 279-285, 1995.[CrossRef][Web of Science][Medline]
  3. Azzi A, Montecucco C, and Richter C. The use of acetylated ferricytochrome c for the detection of superoxide radicals produced in biological membranes. Biochem Biophys Res Commun 65: 597-603, 1975.[CrossRef][Web of Science][Medline]
  4. Ballou D, Palmer G, and Massey V. Direct demonstration of superoxide anion production during the oxidation of reduced flavin and of its catalytic decomposition by erythrocuprein. Biochem Biophys Res Commun 36: 898-904, 1969.[CrossRef][Web of Science][Medline]
  5. Barbacanne MA, Souchard JP, Darblade B, Iliou JP, Nepveu F, Pipy B, Bayard F, and Arnal JF. Detection of superoxide anion released extracellularly by endothelial cells using cytochrome c reduction, ESR, fluorescence and lucigenin-enhanced chemiluminescence techniques. Free Radic Biol Med 29: 388-396, 2000.[CrossRef][Web of Science][Medline]
  6. Bass DA, Parce JW, Dechatelet LR, Szejda P, Seeds MC, and Thomas M. Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J Immunol 130: 1910-1917, 1983.[Abstract]
  7. Beckman JS and Koppenol WH. Nitric oxide superoxide and peroxynitrite: the good, the bad, and ugly. Am J Physiol Cell Physiol 271: C1424-C1437, 1996.[Abstract/Free Full Text]
  8. Benov L, Sztejnberg L, and Fridovich I. Critical evaluation of the use of hydroethidine as a measure of superoxide anion radical. Free Radic Biol Med 25: 826-831, 1998.[CrossRef][Web of Science][Medline]
  9. Bindokas VP, Jordan J, Lee CC, and Miller RJ. Superoxide production in rat hippocampal neurons: selective imaging with hydroethidine. J Neurosci 16: 1324-1336, 1996.[Abstract/Free Full Text]
  10. Borbat PP, Costa-Filho AJ, Earle KA, Moscicki JK, and Freed JH. Electron spin resonance in studies of membranes and proteins. Science 291: 266-269, 2001.[Abstract/Free Full Text]
  11. Boveris A. Determination of the production of superoxide radicals and hydrogen peroxide in mitochondria. Methods Enzymol 105: 429-435, 1984.[Web of Science][Medline]
  12. Boveris A, Martino E, and Stoppani AO. Evaluation of the horseradish peroxidase-scopoletin method for the measurement of hydrogen peroxide formation in biological systems. Anal Biochem 80: 145-158, 1977.[CrossRef][Web of Science][Medline]
  13. Brawn K and Fridovich I. Superoxide radical and superoxide dismutases: threat and defense. Acta Physiol Scand 492: 9-18, 1980.
  14. Brennan ML, Wu W, Fu X, Shen Z, Song W, Frost H, Vadseth C, Narine L, Lenkiewicz E, Borchers MT, Lusis AJ, Lee JJ, Lee NA, Abu-Soud HM, Ischiropoulos H, and Hazen SL. A tale of two controversies: defining both the role of peroxidases in nitrotyrosine formation in vivo using eosinophil peroxidase and myeloperoxidase-deficient mice, and the nature of peroxidase-generated reactive nitrogen species. J Biol Chem 277: 17415-17427, 2002.[Abstract/Free Full Text]
  15. Budd SL, Castilho RF, and Nicholls DG. Mitochondrial membrane potential and hydroethidine-monitored superoxide generation in cultured cerebellar granule cells. FEBS Lett 415: 21-24, 1997.[CrossRef][Web of Science][Medline]
  16. Burkitt MJ and Wardman P. Cytochrome c is a potent catalyst of dichlorofluorescin oxidation: implications for the role of reactive oxygen species in apoptosis. Biochem Biophys Res Commun 282: 329-333, 2001.[CrossRef][Web of Science][Medline]
  17. Cai J, Yang J, and Jones DP. Mitochondrial control of apoptosis: the role of cytochrome c. Biochim Biophys Acta 1366: 139-149, 1998.[Medline]
  18. Carter WO, Narayanan PK, and Robinson JP. Intracellular hydrogen peroxide and superoxide anion detection in endothelial cells. J Leukoc Biol 55: 253-258, 1994.[Abstract]
  19. Castro L, Rodriguez M, and Radi R. Aconitase is readily inactivated by peroxynitrite, but not by its precursor, nitric oxide. J Biol Chem 269: 29409-29415, 1994.[Abstract/Free Full Text]
  20. Cathcart R, Schwiers E, and Ames BN. Detection of picomole levels of hydroperoxides using a fluorescent dichlorofluorescein assay. Anal Biochem 134: 111-116, 1983.[CrossRef][Web of Science][Medline]
  21. Cohen G, Kim M, and Ogwu V. A modified catalase assay suitable for a plate reader and for the analysis of brain cell cultures. J Neurosci Methods 67: 53-56, 1996.[CrossRef][Web of Science][Medline]
  22. Crow JP. Dichlorodihydrofluorescein and dihydrorhodamine 123 are sensitive indicators of peroxynitrite in vitro: implications for intracellular measurement of reactive nitrogen and oxygen species. Nitric Oxide 1: 145-157, 1997.[CrossRef][Web of Science][Medline]
  23. Dambrova M, Baumane L, Kalvinsh I, and Wikberg JE. Improved method for EPR detection of DEPMPO-superoxide radicals by liquid nitrogen freezing. Biochem Biophys Res Commun 275: 895-898, 2000.[CrossRef][Web of Science][Medline]
  24. Dikalov S, Skatchkov M, and Bassenge E. Spin trapping of superoxide radicals and peroxynitrite by 1-hydroxy-3-carboxy-pyrrolidine and 1-hydroxy-2,2,6,6-tetramethyl-4-oxo-piperidine and the stability of corresponding nitroxyl radicals towards biological reductants. Biochem Biophys Res Commun 231: 701-704, 1997.[CrossRef][Web of Science][Medline]
  25. Duerrschmidt N, Wippich N, Goettsch W, Broemme HJ, and Morawietz H. Endothelin-1 induces NAD(P)H oxidase in human endothelial cells. Biochem Biophys Res Commun 269: 713-717, 2000.[CrossRef][Web of Science][Medline]
  26. Eiserich JP, Baldus S, Brennan ML, Ma W, Zhang C, Tousson A, Castro L, Lusis AJ, Nauseef WM, White CR, and Freeman BA. Myeloperoxidase, a leukocyte-derived vascular NO oxidase. Science 296: 2391-2394, 2002.[Abstract/Free Full Text]
  27. Eiserich JP, Cross CE, Jones AD, Halliwell B, and van der Vliet A. Formation of nitrating and chlorinating species by reaction of nitrite with hypochlorous acid. A novel mechanism for nitric oxide-mediated protein modification. J Biol Chem 271: 19199-19208, 1996.[Abstract/Free Full Text]
  28. Eiserich JP, Hristova M, Cross CE, Jones AD, Freeman BA, Halli-well B, and van der Vliet A. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 391: 393-397, 1998.[CrossRef][Medline]
  29. Espey MG, Miranda KM, Thomas DD, and Wink DA. Distinction between nitrosating mechanisms within human cells and aqueous solution. J Biol Chem 276: 30085-30091, 2001.[Abstract/Free Full Text]
  30. Espey MG, Miranda KM, Thomas DD, and Wink DA. Ingress and reactive chemistry of nitroxyl-derived species within human cells. Free Radic Biol Med 33: 827-834, 2002.[CrossRef][Web of Science][Medline]
  31. Espey MG, Thomas DD, Miranda KM, and Wink DA. Focusing of nitric oxide mediated nitrosation and oxidative nitrosylation as a consequence of reaction with superoxide. Proc Natl Acad Sci USA 99: 11127-11132, 2002.[Abstract/Free Full Text]
  32. Flint DH, Tuminello JF, and Emptage MH. The inactivation of Fe-S cluster containing hydro-lyases by superoxide. J Biol Chem 268: 22369-22376, 1993.[Abstract/Free Full Text]
  33. Frejaville C, Karoui H, Tuccio B, Le Moigne F, Culcasi M, Pietri S, Lauricella R, and Tordo P. 5-(Diethoxyphosphoryl)-5-methyl-1-pyrroline N-oxide: a new efficient phosphorylated nitrone for the in vitro and in vivo spin trapping of oxygen-centered radicals. J Med Chem 38: 258-265, 1995.[CrossRef][Web of Science][Medline]
  34. Fridovich I. Cytochrome c. In: Handbook of Methods for Oxygen Radical Research, edited by Greenwald RA. Boca Raton, FL: CRC, 1985, p. 121-122.
  35. Fujii H and Berliner LJ. Nitric oxide: prospects and perspectives of in vivo detection by L-band EPR spectroscopy. Phys Med Biol 43: 1949-1956, 1998.[CrossRef][Web of Science][Medline]
  36. Gardner PR and Fridovich I. Inactivation-reactivation of aconitase in Escherichia coli. A sensitive measure of superoxide radical. J Biol Chem 267: 8757-8763, 1992.[Abstract/Free Full Text]
  37. Gardner PR, Nguyen DD, and White CW. Superoxide scavenging by Mn(II/III) tetrakis (1-methyl-4-pyridyl) porphyrin in mammalian cells. Arch Biochem Biophys 325: 20-28, 1996.[CrossRef][Web of Science][Medline]
  38. Gardner PR, Raineri I, Epstein LB, and White CW. Superoxide radical and iron modulate aconitase activity in mammalian cells. J Biol Chem 270: 13399-13405, 1995.[Abstract/Free Full Text]
  39. Goto T, Inoue S, Sugiura S, Nishikawa K, Isobe M, and Abe Y. Cypridina bioluminescence V structure of emitting species in the luminescence of Cypridina luciferin and its related compounds. Tetrahedron Lett 37: 4035-4038, 1968.[Medline]
  40. Gow AJ and Stamler JS. Reactions between nitric oxide and haemoglobin under physiological conditions. Nature 391: 169-173, 1998.[CrossRef][Medline]
  41. Granger DL, Taintor RR, Boockvar KS, and Hibbs JB Jr. Measurement of nitrate and nitrite in biological samples using nitrate reductase and Griess reaction. Methods Enzymol 268: 142-151, 1996.[Web of Science][Medline]
  42. Green DR and Reed JC. Mitochondria and apoptosis. Science 281: 1309-1312, 1998.[Abstract/Free Full Text]
  43. Grisham MB. Oxidants and free radicals in inflammatory bowel disease. Lancet 344: 859-861, 1994.[CrossRef][Web of Science][Medline]
  44. Grisham MB, Johnson GG, and Lancaster JR Jr. Quantitation of nitrate and nitrite in extracellular fluids. Methods Enzymol 268: 237-246, 1996.[Web of Science][Medline]
  45. Guidet B and Shah SV. Enhanced in vivo H2O2 generation by rat kidney in glycerol-induced renal failure. Am J Physiol Renal Fluid Electrolyte Physiol 257: F440-F445, 1989.[Abstract/Free Full Text]
  46. Halliwell B. How to characterize an antioxidant: an update. Biochem Soc Symp 61: 73-101, 1995.[Medline]
  47. Halliwell B and Gutteridge JMC. Detection of free radicals and other reactive species: trapping and finger printing. In: Free Radicals in Biology and Medicine, edited by Halliwell B and Gutteridge JMC. Oxford, UK: Oxford Press, 2000, p. 351-429.
  48. Hausladen A and Fridovich I. Superoxide and peroxynitrite inactivate aconitases, but nitric oxide does not. J Biol Chem 269: 29405-29408, 1994.[Abstract/Free Full Text]
  49. Hausladen A and Fridovich I. Measuring nitric oxide and superoxide: rate constants for aconitase reactivity. Methods Enzymol 269: 37-41, 1996.[Web of Science][Medline]
  50. He G, Samouilov A, Kuppusamy P, and Zweier JL. In vivo imaging of free radicals: applications from mouse to man. Mol Cell Biochem 234-235: 359-367, 2002.[CrossRef][Medline]
  51. Hink U, Li H, Mollnau H, Oelze M, Matheis E, Hartmann M, Skatchkov M, Thaiss F, Stahl RA, Warnholtz A, Meinertz T, Griendling K, Harrison DG, Forstermann U, and Munzel T. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res 88: E14-E22, 2001.[Abstract/Free Full Text]
  52. Hinkle PC, Butow RA, Racker E, and Chance B. Partial resolution of the enzymes catalyzing oxidative phosphorylation. XV Reverse electron transfer in the flavin-cytochrome beta region of the respiratory chain of beef heart submitochondrial particles. J Biol Chem 242: 5169-5173, 1967.[Abstract/Free Full Text]
  53. Huang X, Frenkel K, Klein CB, and Costa M. Nickel induces increased oxidants in intact cultured mammalian cells as detected by dichlorofluorescein fluorescence. Toxicol Appl Pharmacol 120: 29-36, 1993.[CrossRef][Web of Science][Medline]
  54. Hyslop PA and Sklar LA. A quantitative fluorimetric assay for the determination of oxidant production by polymorphonuclear leukocytes: its use in the simultaneous fluorimetric assay of cellular activation processes. Anal Biochem 141: 280-286, 1984.[CrossRef][Web of Science][Medline]
  55. Ignarro LJ. Nitric oxide as a unique signaling molecule in the vascular system: a historical overview. J Physiol Pharmacol 53: 503-514, 2002.[Web of Science][Medline]
  56. Ignarro LJ, Fukuto JM, Griscavage JM, Rogers NE, and Byrns RE. Oxidation of nitric oxide in aqueous solution to nitrite but not nitrate: comparison with enzymatically formed nitric oxide from L-arginine. Proc Natl Acad Sci USA 90: 8103-8107, 1993.[Abstract/Free Full Text]
  57. Ishii M, Shimizu S, Yamamoto T, Momose K, and Kuroiwa Y. Acceleration of oxidative stress-induced endothelial cell death by nitric oxide synthase dysfunction accompanied with decrease in tetrahydrobiopterin content. Life Sci 61: 739-747, 1997.[CrossRef][Web of Science][Medline]
  58. Janiszewski M, Souza HP, Liu X, Pedro MA, Zweier JL, and Laurindo FR. Overestimation of NADH-driven vascular oxidase activity due to lucigenin artifacts. Free Radic Biol Med 32: 446-453, 2002.[CrossRef][Web of Science][Medline]
  59. Jia L, Bonaventura C, Bonaventura J, and Stamler JS. S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature 380: 221-226, 1996.[CrossRef][Medline]
  60. Jones DP. Redox potential of GSH/GSSG couple: assay and biological significance. Methods Enzymol 348: 93-112, 2002.[Web of Science][Medline]
  61. Jourd'heuil D, Gray L, and Grisham MB. S-nitrosothiol formation in blood of lipopolysaccharide-treated rats. Biochem Biophys Res Commun 273: 22-26, 2000.[CrossRef][Web of Science][Medline]
  62. Jourd'heuil D, Hallen K, Feelisch M, and Grisham MB. Dynamic state of S-nitrosothiols in human plasma and whole blood. Free Radic Biol Med 28: 409-417, 2000.[CrossRef][Web of Science][Medline]
  63. Keston AS and Brandt R. The fluorometric analysis of ultramicro quantities of hydrogen peroxide. Anal Biochem 11: 1-5, 1965.[CrossRef][Web of Science][Medline]
  64. Kilinc K, Kilinc A, Wolf RE, and Grisham MB. Myoglobin-catalyzed tyrosine nitration: no need for peroxynitrite. Biochem Biophys Res Commun 285: 273-276, 2001.[CrossRef][Web of Science][Medline]
  65. Kinnula VL, Mirza Z, Crapo JD, and Whorton AR. Modulation of hydrogen peroxide release from vascular endothelial cells by oxygen. Am J Respir Cell Mol Biol 9: 603-609, 1993.
  66. Kojima H, Hirotani M, Nakatsubo N, Kikuchi K, Urano Y, Higuchi T, Hirata Y, and Nagano T. Bioimaging of nitric oxide with fluorescent indicators based on the rhodamine chromophore. Anal Chem 73: 1967-1973, 2001.[Medline]
  67. Kojima H, Nakatsubo N, Kikuchi K, Kawahara S, Kirino Y, Nagoshi H, Hirata Y, and Nagano T. Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins. Anal Chem 70: 2446-2453, 1998.[Medline]
  68. Kooy NW, Royall JA, and Ischiropoulos H. Oxidation of 2',7'-dichlorofluorescin by peroxynitrite. Free Radic Res 27: 245-254, 1997.[Web of Science][Medline]
  69. Kuthan H, Ullrich V, and Estabrook RW. A quantitative test for superoxide radicals produced in biological systems. Biochem J 203: 551-558, 1982.[Web of Science][Medline]
  70. Land EJ and Swallow AJ. One-electron reactions in biochemical systems as studied by pulse radiolysis. V. Cytochrome c. Arch Biochem Biophys 145: 365-372, 1971.[CrossRef][Web of Science][Medline]
  71. Landmesser U, Dikalov S, Price SR, McCann L, Fukai T, Holland SM, Mitch WE, and Harrison DG. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 111: 1201-1209, 2003.[CrossRef][Web of Science][Medline]
  72. Larsen LN, Dahl E, and Bremer J. Peroxidative oxidation of leuco-dichlorofluorescein by prostaglandin H synthase in prostaglandin biosynthesis from polyunsaturated fatty acids. Biochim Biophys Acta 1299: 47-53, 1996.[Medline]
  73. Laurindo FR, Pedro MD Barbeiro HV, Pileggi F, Carvalho MH, Augusto O, and da Luz PL. Vascular free radical release ex vivo and in vivo evidence for a flow-dependent endothelial mechanism. Circ Res 74: 700-709, 1994.[Abstract/Free Full Text]
  74. LeBel CP, Ischiropoulos H, and Bondy SC. Evaluation of the probe 2',7'-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem Res Toxicol 5: 227-231, 1992.[CrossRef][Web of Science][Medline]
  75. Liochev SI and Fridovich I. Lucigenin (bis-N-methylacridinium) as a mediator of superoxide anion production. Arch Biochem Biophys 337: 115-120, 1997.[CrossRef][Web of Science][Medline]
  76. Liu X, Miller MJ, Joshi MS, Thomas DD, and Lancaster JR Jr. Accelerated reaction of nitric oxide with O2 within the hydrophobic interior of biological membranes. Proc Natl Acad Sci USA 95: 2175-2179, 1998.[Abstract/Free Full Text]
  77. Lucas M and Solano F. Coelenterazine is a superoxide anion-sensitive chemiluminescent probe: its usefulness in the assay of respiratory burst in neutrophils. Anal Biochem 206: 273-277, 1992.[CrossRef][Web of Science][Medline]
  78. Lynch RE and Fridovich I. Permeation of the erythrocyte stroma by superoxide radical. J Biol Chem 253: 4697-4699, 1978.[Abstract/Free Full Text]
  79. Makino K, Hagiwara T, Hagi A, Nishi M, and Murakami A. Cautionary note for DMPO spin trapping in the presence of iron ion. Biochem Biophys Res Commun 172: 1073-1080, 1990.[CrossRef][Web of Science][Medline]
  80. Margoliash E, Novogrodsky A, and Schejter A. Irreversible reaction of 3-amino 1:2,4-triazole and related inhibitors with the protein catalase. Biochem J 74: 339-348, 1960.[Web of Science][Medline]
  81. Marklund SL and Karlsson K. Extracellular-superoxide dismutase, distribution in the body and therapeutic applications. Adv Exp Med Biol 264: 1-4, 1990.[Medline]
  82. Massey V. The microestimation of succinate and the extinction coefficient of cytochrome c. Biochim Biophys Acta 34: 255-256, 1959.[Medline]
  83. McCord JM and Fridovich I. The reduction of cytochrome c by milk xanthine oxidase. J Biol Chem 243: 5753-5760, 1968.[Abstract/Free Full Text]
  84. McCord JM and Fridovich I. The utility of superoxide dismutase in studying free radical reactions. I. Radicals generated by the interaction of sulfite, dimethyl sulfoxide, and oxygen. J Biol Chem 244: 6056-6063, 1969.[Abstract/Free Full Text]
  85. Melov S, Coskun P, Patel M, Tuinstra R, Cottrell B, Jun AS, Zastawny TH, Dizdaroglu M, Goodman SI, Huang TT, Miziorko H, Epstein CJ, and Wallace DC. Mitochondrial disease in superoxide dismutase 2 mutant mice. Proc Natl Acad Sci USA 96: 846-851, 1999.[Abstract/Free Full Text]
  86. Miles AM, Wink DA, Cook JC, and Grisham MB. Determination of nitric oxide using fluorescence spectroscopy. Methods Enzymol 268: 105-120, 1996.[Web of Science][Medline]
  87. Miller FJ, Gutterman DD, Rios CD, Heistad DD, and Davidson BL. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res 82: 1298-1305, 1998.[Abstract/Free Full Text]
  88. Miranda KM, Yamada K, Espey MG, Thomas DD, DeGraff W, Mitchell JB, Krishna MC, Colton CA, and Wink DA. Further evidence for distinct reactive intermediates from nitroxyl and peroxynitrite: effects of buffer composition on the chemistry of Angeli's salt and synthetic peroxynitrite. Arch Biochem Biophys 401: 134-144, 2002.[CrossRef][Web of Science][Medline]
  89. Miranda KM, Espey MG, Yamada K, Krishna M, Ludwick N, Kim S, Jourd'heuil D, Grisham MB, Feelisch M, Fukuto JM, and Wink DA. Unique oxidative mechanisms for the reactive nitrogen oxide species, nitroxyl anion. J Biol Chem 276: 1720-1727, 2001.[Abstract/Free Full Text]
  90. Morrow JD, Hill KE, Burk RF, Nammour TM, Badr KF, and Roberts LJ. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 87: 9383-9387, 1990.[Abstract/Free Full Text]
  91. Munzel T, Afanas'ev IB, Kleschyov AL, and Harrison DG. Detection of superoxide in vascular tissue. Arterioscler Thromb Vasc Biol 22: 1761-1768, 2002.[Abstract/Free Full Text]
  92. Nakano M. Assay for superoxide dismutase based on chemiluminescence of luciferin analog. Methods Enzymol 186: 227-232, 1990.[Medline]
  93. Nakano M. Determination of superoxide radical and singlet oxygen based on chemiluminescence of luciferin analogs. Methods Enzymol 186: 585-591, 1990.[Medline]
  94. Nakano M, Sugioka K, Ushijima Y, and Goto T. Chemiluminescence probe with Cypridina luciferin analog, 2-methyl-6-phenyl-3,7-dihydroimidazo[1,2-a]pyrazin-3-one, for estimating the ability of human granulocytes to generate O2-. Anal Biochem 159: 363-369, 1986.[CrossRef][Web of Science][Medline]
  95. O'Brien PJ. Superoxide production. Methods Enzymol 105: 370-378, 1984.[Web of Science][Medline]
  96. Ohashi T, Mizutani A, Murakami A, Kojo S, Ishii T, and Taketani S. Rapid oxidation of dichlorodihydrofluorescin with heme and hemoproteins: formation of the fluorescein is independent of the generation of reactive oxygen species. FEBS Lett 511: 21-27, 2002.[CrossRef][Web of Science][Medline]
  97. Ohshima H, Celan I, Chazotte L, Pignatelli B, and Mower HF. Analysis of 3-nitrotyrosine in biological fluids and protein hydrolyzates by high-performance liquid chromatography using a postseparation, online reduction column and electrochemical detection: results with various nitrating agents. Nitric Oxide 3: 132-141, 1999.[CrossRef][Web of Science][Medline]
  98. Paler-Martinez A, Panus PC, Chumley PH, Ryan U, Hardy MM, and Freeman BA. Endogenous xanthine oxidase does not significantly contribute to vascular endothelial production of reactive oxygen species. Arch Biochem Biophys 311: 79-85, 1994.[CrossRef][Web of Science][Medline]
  99. Patel M, Day BJ, Crapo JD, Fridovich I, and McNamara JO. Requirement for superoxide in excitotoxic cell death. Neuron 16: 345-355, 1996.[CrossRef][Web of Science][Medline]
  100. Paul B and Sbarra AJ. The role of the phagocyte in host-parasite interactions. 13. The direct quantitative estimation of H2O2 in phagocytizing cells. Biochim Biophys Acta 156: 168-178, 1968.[Medline]
  101. Pfeiffer S, Gorren AC, Schmidt K, Werner ER, Hansert B, Bohle DS, and Mayer B. Metabolic fate of peroxynitrite in aqueous solution. Reaction with nitric oxide and pH-dependent decomposition to nitrite and oxygen in a 2:1 stoichiometry. J Biol Chem 272: 3465-3470, 1997.[Abstract/Free Full Text]
  102. Piantadosi CA and Tatro LG. Regional H2O2 concentration in rat brain after hyperoxic convulsions. J Appl Physiol 69: 1761-1766, 1990.[Abstract/Free Full Text]
  103. Pick E and Keisari Y. A simple colorimetric method for the measurement of hydrogen peroxide produced by cells in culture. J Immunol Methods 38: 161-170, 1980.[CrossRef][Web of Science][Medline]
  104. Prutz WA, Monig H, Butler J, and Land EJ. Reactions of nitrogen dioxide in aqueous model systems: oxidation of tyrosine units in peptides and proteins. Arch Biochem Biophys 243: 125-134, 1985.[CrossRef][Web of Science][Medline]
  105. Pryor WA, Stanley JP, and Blair E. Autoxidation of polyunsaturated fatty acids: II. A suggested mechanism for the formation of TBA-reactive materials from prostaglandin-like endoperoxides. Lipids 11: 370-379, 1976.[Web of Science][Medline]
  106. Quaresima V and Ferrari M. Current status of electron spin resonance (ESR) for in vivo detection of free radicals. Phys Med Biol 43: 1937-1947, 1998.[CrossRef][Web of Science][Medline]
  107. Raha S, McEachern GE, Myint AT, and Robinson BH. Superoxides from mitochondrial complex III: the role of manganese superoxide dismutase. Free Radic Biol Med 29: 170-180, 2000.[CrossRef][Web of Science][Medline]
  108. Rice-Evans CA and Diplock AT. Current status of antioxidant therapy. Free Radic Biol Med 15: 77-96, 1993.[CrossRef][Web of Science][Medline]
  109. Roberts LJ and Morrow JD. Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 28: 505-513, 2000.[CrossRef][Web of Science][Medline]
  110. Rosen GM and Freeman BA. Detection of superoxide generated by endothelial cells. Proc Natl Acad Sci USA 81: 7269-7273, 1984.[Abstract/Free Full Text]
  111. Rota C, Chignell CF, and Mason RP. Evidence for free radical formation during the oxidation of 2'-7'-dichlorofluorescin to the fluorescent dye 2'-7'-dichlorofluorescein by horseradish peroxidase: possible implications for oxidative stress measurements. Free Radic Biol Med 27: 873-881, 1999.[CrossRef][Web of Science][Medline]
  112. Rota C, Fann YC, and Mason RP. Phenoxyl free radical formation during the oxidation of the fluorescent dye 2',7'-dichlorofluorescein by horseradish peroxidase. Possible consequences for oxidative stress measurements. J Biol Chem 274: 28161-28168, 1999.[Abstract/Free Full Text]
  113. Rothe G and Valet G. Flow cytometric analysis of respiratory burst activity in phagocytes with hydroethidine and 2',7'-dichlorofluorescin. J Leukoc Biol 47: 440-448, 1990.[Abstract]
  114. Roubaud V, Sankarapandi S, Kuppusamy P, Tordo P, and Zweier JL. Quantitative measurement of superoxide generation using the spin trap 5-(diethoxyphosphoryl)-5-methyl-1-pyrroline-N-oxide. Anal Biochem 247: 404-411, 1997.[CrossRef][Web of Science][Medline]
  115. Royall JA and Ischiropoulos H. Evaluation of 2',7'-dichlorofluorescin and dihydrorhodamine 123 as fluorescent probes for intracellular H2O2 in cultured endothelial cells. Arch Biochem Biophys 302: 348-355, 1993.[CrossRef][Web of Science][Medline]
  116. Ruch W, Cooper PH, and Baggiolini M. Assay of H2O2 production by macrophages and neutrophils with homovanillic acid and horse-radish peroxidase. J Immunol Methods 63: 347-357, 1983.[CrossRef][Web of Science][Medline]
  117. Saitoh D, Kadota T, Okada Y, Masuda Y, Ohno H, and Inoue M. Direct evidence for the occurrence of superoxide radicals in the small intestine of the burned rat. Am J Emerg Med 13: 37-40, 1995.[CrossRef][Web of Science][Medline]
  118. Senft AP, Dalton TP, Nebert DW, Genter MB, Hutchinson RJ, and Shertzer HG. Dioxin increases reactive oxygen production in mouse liver mitochondria. Toxicol Appl Pharmacol 178: 15-21, 2002.[CrossRef][Web of Science][Medline]
  119. Shimomura O and Johnson FH. Peroxidized coelenterazine, the active group in the photoprotein aequorin. Proc Natl Acad Sci USA 75: 2611-2615, 1978.[Abstract/Free Full Text]
  120. Skatchkov MP, Sperling D, Hink U, Anggard E, and Munzel T. Quantification of superoxide radical formation in intact vascular tissue using a Cypridina luciferin analog as an alternative to lucigenin. Biochem Biophys Res Commun 248: 382-386, 1998.[CrossRef][Web of Science][Medline]
  121. Skatchkov MP, Sperling D, Hink U, Mulsch A, Harrison DG, Sindermann I, Meinertz T, and Munzel T. Validation of lucigenin as a chemiluminescent probe to monitor vascular superoxide as well as basal vascular nitric oxide production. Biochem Biophys Res Commun 254: 319-324, 1999.[CrossRef][Web of Science][Medline]
  122. Skulachev VP. Membrane-linked systems preventing superoxide formation. Biosci Rep 17: 347-366, 1997.[CrossRef][Web of Science][Medline]
  123. Sorescu D, Weiss D, Lassegue B, Clempus RE, Szocs K, Sorescu GP, Valppu L, Quinn MT, Lambeth JD, Vega JD, Taylor WR, and Griendling KK. Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation 105: 1429-1435, 2002.[Abstract/Free Full Text]
  124. Souza HP, Souza LC, Anastacio VM, Pereira AC, Junqueira ML, Krieger JE, da Luz PL, Augusto O, and Laurindo FR. Vascular oxidant stress early after balloon injury: evidence for increased NAD(P)H oxidoreductase activity. Free Radic Biol Med 28: 1232-1242, 2000.[CrossRef][Web of Science][Medline]
  125. Stamler JS. S-nitrosothiols and the bioregulatory actions of nitrogen oxides through reactions with thiol groups. Curr Top Microbiol Immunol 196: 19-36, 1995.[Medline]
  126. Stamler JS, Simon DI, Osborne JA, Mullins ME, Jaraki O, Michel T, Singel DJ, and Loscalzo J. S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc Natl Acad Sci USA 89: 444-448, 1992.[Abstract/Free Full Text]
  127. Staniek K and Nohl H. H(2)O(2) detection from intact mitochondria as a measure for one-electron reduction of dioxygen requires a non-invasive assay system. Biochim Biophys Acta 1413: 70-80, 1999.[Medline]
  128. Sugioka K, Nakano M, Kurashige S, Akuzawa Y, and Goto T. A chemiluminescent probe with a Cypridina luciferin analog, 2-methyl-6-phenyl-3,7-dihydroimidazo[1,2-a]pyrazin-3-one, specific and sensitive for O2- production in phagocytizing macrophages. FEBS Lett 197: 27-30, 1986.[CrossRef][Web of Science][Medline]
  129. Suzuki H, Swei A, Zweifach BW, and Schmid-Schonbein GW. In vivo evidence for microvascular oxidative stress in spontaneously hypertensive rats Hydroethidine microfluorography. Hypertension 25: 1083-1089, 1995.[Abstract/Free Full Text]
  130. Takahashi A, Nakano M, Mashiko S, and Inaba H. The first observation of O2- generation in in situ lungs of rats treated with drugs to induce experimental acute respiratory distress syndrome. FEBS Lett 261: 369-372, 1990.[CrossRef][Web of Science][Medline]
  131. Tampo Y, Kotamraju S, Chitambar CR, Kalivendi SV, Keszler A, Joseph J, and Kalyanaraman B. Oxidative stress-induced iron signaling is responsible for peroxide-dependent oxidation of dichlorodihydrofluorescein in endothelial cells: role of transferrin receptor-dependent iron uptake in apoptosis. Circ Res 92: 56-63, 2003.[Abstract/Free Full Text]
  132. Tanaka M, Sotomatsu A, Yoshida T, Hirai S, and Nishida A. Detection of superoxide production by activated microglia using a sensitive and specific chemiluminescence assay and microglia-mediated PC12h cell death. J Neurochem 63: 266-270, 1994.[Web of Science][Medline]
  133. Tarpey MM and Fridovich I. Methods of detection of vascular reactive species: nitric oxide, superoxide, hydrogen peroxide, and peroxynitrite. Circ Res 89: 224-236, 2001.[Abstract/Free Full Text]
  134. Tarpey MM, White CR, Suarez E, Richardson G, Radi R, and Freeman BA. Chemiluminescent detection of oxidants in vascular tissue: lucigenin but not coelenterazine enhances superoxide formation. Circ Res 84: 1203-1211, 1999.[Abstract/Free Full Text]
  135. Teranishi K and Shimomura O. Coelenterazine analogs as chemiluminescent probe for superoxide anion. Anal Biochem 249: 37-43, 1997.[CrossRef][Web of Science][Medline]
  136. Thomas DD, Espey MG, Vitek MP, Miranda KM, and Wink DA. Protein nitration is mediated by heme and free metals through Fenton-type chemistry: an alternative to the NO/O2-reaction. Proc Natl Acad Sci USA 99: 12691-12696, 2002.[Abstract/Free Full Text]
  137. Thomson L, Trujillo M, Telleri R, and Radi R. Kinetics of cytochrome c2+ oxidation by peroxynitrite: implications for superoxide measurements in nitric oxide-producing biological systems. Arch Biochem Biophys 319: 491-497, 1995.[CrossRef][Web of Science][Medline]
  138. Uehara K, Maruyama N, Huang CK, and Nakano M. The first application of a chemiluminescence probe, 2-methyl-6-[p-methoxyphenyl]-3,7-dihydroimidazo[1,2-a]pyrazin-3-one (MCLA), for detecting O2-production, in vitro, from Kupffer cells stimulated by phorbol myristate acetate. FEBS Lett 335: 167-170, 1993.[CrossRef][Web of Science][Medline]
  139. Ushiroda S, Maruyama Y, and Nakano M. Continuous detection of superoxide in situ during ischemia and reperfusion in the rabbit heart. Jpn Heart J 38: 91-105, 1997.[Medline]
  140. Vasquez-Vivar J, Hogg N, Pritchard KA Jr, Martasek P, and Kalyanaraman B. Superoxide anion formation from lucigenin: an electron spin resonance spin-trapping study. FEBS Lett 403: 127-130, 1997.[CrossRef][Web of Science][Medline]
  141. Vasquez-Vivar J, Kalyanaraman B, and Kennedy MC. Mitochondrial aconitase is a source of hydroxyl radical. An electron spin resonance investigation. J Biol Chem 275: 14064-14069, 2000.[Abstract/Free Full Text]
  142. Velan SS, Spencer RG, Zweier JL, and Kuppusamy P. Electron paramagnetic resonance oxygen mapping (EPROM): direct visualization of oxygen concentration in tissue. Magn Reson Med 43: 804-809, 2000.[CrossRef][Web of Science][Medline]
  143. Williams MD, Van Remmen H, Conrad CC, Huang TT, Epstein CJ, and Richardson A. Increased oxidative damage is correlated to altered mitochondrial function in heterozygous manganese superoxide dismutase knockout mice. J Biol Chem 273: 28510-28515, 1998.[Abstract/Free Full Text]
  144. Wink DA, Kim S, Coffin D, Cook JC, Vodovotz Y, Chistodoulou D, Jourd'heuil D, and Grisham MB. Detection of S-nitrosothiols by fluorometric and colorimetric methods. Methods Enzymol 301: 201-211, 1999.[CrossRef][Web of Science][Medline]
  145. Yusa T, Beckman JS, Crapo JD, and Freeman BA. Hyperoxia increases H2O2 production by brain in vivo. J Appl Physiol 63: 353-358, 1987.[Abstract/Free Full Text]
  146. Zhao H, Kalivendi SV, Joseph J, Zhang H, and Kalyanaraman B. Superoxide reacts with hydroethidine but forms a fluorescent product that is distinctly different from ethidium (Abstract). Free Radic Biol Med 33: S425, 2002.[CrossRef]
  147. Zhou M, Diwu Z, Panchuk-Voloshina N, and Haugland RP. A stable nonfluorescent derivative of resorufin for the fluorometric determination of trace hydrogen peroxide: applications in detecting the activity of phagocyte NADPH oxidase and other oxidases. Anal Biochem 253: 162-168, 1997.[CrossRef][Web of Science][Medline]



This article has been cited by other articles:


Home page
MutagenesisHome page
S.H. Doak, S.M. Griffiths, B. Manshian, N. Singh, P.M. Williams, A.P. Brown, and G.J.S. Jenkins
Confounding experimental considerations in nanogenotoxicology
Mutagenesis, July 1, 2009; 24(4): 285 - 293.
[Abstract] [Full Text] [PDF]


Home page
Plant Physiol.Home page
K. Oracz, H. El-Maarouf-Bouteau, I. Kranner, R. Bogatek, F. Corbineau, and C. Bailly
The Mechanisms Involved in Seed Dormancy Alleviation by Hydrogen Cyanide Unravel the Role of Reactive Oxygen Species as Key Factors of Cellular Signaling during Germination
Plant Physiology, May 1, 2009; 150(1): 494 - 505.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Z. Han, S. Varadharaj, R. J. Giedt, J. L. Zweier, H. H. Szeto, and B. R. Alevriadou
Mitochondria-Derived Reactive Oxygen Species Mediate Heme Oxygenase-1 Expression in Sheared Endothelial Cells
J. Pharmacol. Exp. Ther., April 1, 2009; 329(1): 94 - 101.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
I V Odinokova, K-F Sung, O A Mareninova, K Hermann, Y Evtodienko, A Andreyev, I Gukovsky, and A S Gukovskaya
Mechanisms regulating cytochrome c release in pancreatic mitochondria
Gut, March 1, 2009; 58(3): 431 - 442.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
F. F. Verit, A. Verit, H. Ciftci, O. Erel, and H. Celik
Paraoxonase-1 Activity in Subfertile Men and Relationship to Sperm Parameters
J Androl, March 1, 2009; 30(2): 183 - 189.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. Brechard and E. J. Tschirhart
Regulation of superoxide production in neutrophils: role of calcium influx
J. Leukoc. Biol., November 1, 2008; 84(5): 1223 - 1237.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
G. A. Prathapasinghe, Y. L. Siow, Z. Xu, and K. O
Inhibition of cystathionine-{beta}-synthase activity during renal ischemia-reperfusion: role of pH and nitric oxide
Am J Physiol Renal Physiol, October 1, 2008; 295(4): F912 - F922.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
E. Hervouet, A. Cizkova, J. Demont, A. Vojtiskova, P. Pecina, N. L.W. Franssen-van Hal, J. Keijer, H. Simonnet, R. Ivanek, S. Kmoch, et al.
HIF and reactive oxygen species regulate oxidative phosphorylation in cancer
Carcinogenesis, August 1, 2008; 29(8): 1528 - 1537.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. R. Kline, D. J. Kleinhenz, B. Liang, S. Dikalov, D. M. Guidot, C. M. Hart, D. P. Jones, and R. L. Sutliff
Vascular oxidative stress and nitric oxide depletion in HIV-1 transgenic rats are reversed by glutathione restoration
Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2792 - H2804.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. C. Juarez, M. Manuia, M. E. Burnett, O. Betancourt, B. Boivin, D. E. Shaw, N. K. Tonks, A. P. Mazar, and F. Donate
Superoxide dismutase 1 (SOD1) is essential for H2O2-mediated oxidation and inactivation of phosphatases in growth factor signaling
PNAS, May 20, 2008; 105(20): 7147 - 7152.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. Pasdois, B. Beauvoit, L. Tariosse, B. Vinassa, S. Bonoron-Adele, and P. D. Santos
Effect of diazoxide on flavoprotein oxidation and reactive oxygen species generation during ischemia-reperfusion: a study on Langendorff-perfused rat hearts using optic fibers
Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2088 - H2097.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
W. Cai, J. C. He, L. Zhu, X. Chen, G. E. Striker, and H. Vlassara
AGE-receptor-1 counteracts cellular oxidant stress induced by AGEs via negative regulation of p66shc-dependent FKHRL1 phosphorylation
Am J Physiol Cell Physiol, January 1, 2008; 294(1): C145 - C152.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
R. A. Oeckler and R. D. Hubmayr
Ventilator-associated lung injury: a search for better therapeutic targets
Eur. Respir. J., December 1, 2007; 30(6): 1216 - 1226.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
G. A. Prathapasinghe, Y. L. Siow, and K. O
Detrimental role of homocysteine in renal ischemia-reperfusion injury
Am J Physiol Renal Physiol, May 1, 2007; 292(5): F1354 - F1363.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. S. Richardson, A. J. Donato, A. Uberoi, D. W. Wray, L. Lawrenson, S. Nishiyama, and D. M. Bailey
Exercise-induced brachial artery vasodilation: role of free radicals
Am J Physiol Heart Circ Physiol, March 1, 2007; 292(3): H1516 - H1522.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
K. C. Kregel and H. J. Zhang
An integrated view of oxidative stress in aging: basic mechanisms, functional effects, and pathological considerations
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2007; 292(1): R18 - R36.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
D. C. Fernandes, J. Wosniak Jr., L. A. Pescatore, M. A. Bertoline, M. Liberman, F. R. M. Laurindo, and C. X. C. Santos
Analysis of DHE-derived oxidation products by HPLC in the assessment of superoxide production and NADPH oxidase activity in vascular systems
Am J Physiol Cell Physiol, January 1, 2007; 292(1): C413 - C422.
[Abstract] [Full Text] [PDF]


Home page
J DAIRY SCIHome page
M. Rinaldi, P. Moroni, L. Leino, J. Laihia, M. J. Paape, and D. D. Bannerman
Effect of cis-urocanic acid on bovine neutrophil generation of reactive oxygen species.
J Dairy Sci, November 1, 2006; 89(11): 4188 - 4201.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Andrukhiv, A. D. Costa, I. C. West, and K. D. Garlid
Opening mitoKATP increases superoxide generation from complex I of the electron transport chain
Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2067 - H2074.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. M. Robinson, M. S. Janes, M. Pehar, J. S. Monette, M. F. Ross, T. M. Hagen, M. P. Murphy, and J. S. Beckman
Selective fluorescent imaging of superoxide in vivo using ethidium-based probes
PNAS, October 10, 2006; 103(41): 15038 - 15043.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. E. Handy and J. Loscalzo
Nitric Oxide and Posttranslational Modification of the Vascular Proteome: S-Nitrosation of Reactive Thiols
Arterioscler. Thromb. Vasc. Biol., June 1, 2006; 26(6): 1207 - 1214.
[Abstract] [Full Text] [PDF]


Home page
Plant Physiol.Home page
V. Shulaev and D. J. Oliver
Metabolic and Proteomic Markers for Oxidative Stress. New Tools for Reactive Oxygen Species Research
Plant Physiology, June 1, 2006; 141(2): 367 - 372.
[Full Text] [PDF]


Home page
Am. J. Pathol.Home page
N. Watanabe, J. W. Zmijewski, W. Takabe, M. Umezu-Goto, C. L. Goffe, A. Sekine, A. Landar, A. Watanabe, J. Aoki, H. Arai, et al.
Activation of Mitogen-Activated Protein Kinases by Lysophosphatidylcholine-Induced Mitochondrial Reactive Oxygen Species Generation in Endothelial Cells
Am. J. Pathol., May 1, 2006; 168(5): 1737 - 1748.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
E. B. Manukhina, H. F. Downey, and R. T. Mallet
Role of nitric oxide in cardiovascular adaptation to intermittent hypoxia.
Experimental Biology and Medicine, April 1, 2006; 231(4): 343 - 365.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
I. Dalle-Donne, R. Rossi, R. Colombo, D. Giustarini, and A. Milzani
Biomarkers of Oxidative Damage in Human Disease
Clin. Chem., April 1, 2006; 52(4): 601 - 623.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
J. Shao, B. Zhou, A. J. Di Bilio, L. Zhu, T. Wang, C. Qi, J. Shih, and Y. Yen
A Ferrous-triapine complex mediates formation of reactive oxygen species that inactivate human ribonucleotide reductase.
Mol. Cancer Ther., March 1, 2006; 5(3): 586 - 592.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. D. Symons, J. C. Rutledge, U. Simonsen, and R. A. Pattathu
Vascular dysfunction produced by hyperhomocysteinemia is more severe in the presence of low folate
Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H181 - H191.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
P. Persson
A look back at a successful year
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2005; 289(6): R1535 - R1535.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
N. Kobayashi, F. A. DeLano, and G. W. Schmid-Schonbein
Oxidative Stress Promotes Endothelial Cell Apoptosis and Loss of Microvessels in the Spontaneously Hypertensive Rats
Arterioscler. Thromb. Vasc. Biol., October 1, 2005; 25(10): 2114 - 2121.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Thakali, S. L. Demel, G. D. Fink, and S. W. Watts
Endothelin-1-induced contraction in veins is independent of hydrogen peroxide
Am J Physiol Heart Circ Physiol, September 1, 2005; 289(3): H1115 - H1122.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
N. Paolocci
Peroxynitrite like Pan?
Cardiovasc Res, August 1, 2005; 67(2): 176 - 178.
[Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
X. Zhou, J. D. Ferraris, Q. Cai, A. Agarwal, and M. B. Burg
Increased reactive oxygen species contribute to high NaCl-induced activation of the osmoregulatory transcription factor TonEBP/OREBP
Am J Physiol Renal Physiol, August 1, 2005; 289(2): F377 - F385.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. L. Gookin, J. Allen, S. Chiang, L. Duckett, and M. U. Armstrong
Local Peroxynitrite Formation Contributes to Early Control of Cryptosporidium parvum Infection
Infect. Immun., July 1, 2005; 73(7): 3929 - 3936.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. M. Touyz, C. Mercure, Y. He, D. Javeshghani, G. Yao, G. E. Callera, A. Yogi, N. Lochard, and T. L. Reudelhuber
Angiotensin II-Dependent Chronic Hypertension and Cardiac Hypertrophy Are Unaffected by gp91phox-Containing NADPH Oxidase
Hypertension, April 1, 2005; 45(4): 530 - 537.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. P. Didion and F. M. Faraci
Ceramide-Induced Impairment of Endothelial Function Is Prevented by CuZn Superoxide Dismutase Overexpression
Arterioscler. Thromb. Vasc. Biol., January 1, 2005; 25(1): 90 - 95.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (94)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tarpey, M. M.
Right arrow Articles by Grisham, M. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tarpey, M. M.
Right arrow Articles by Grisham, M. B.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.